X4 Pharmaceuticals Inc (NASDAQ:XFOR) price on Thursday, December 26, rose 38.91% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.81.
A look at the stock’s price movement, the close in the last trading session was $0.58, moving within a range at $0.6015 and $0.8416. The beta value (5-Year monthly) was 0.388. Turning to its 52-week performance, $1.60 and $0.26 were the 52-week high and 52-week low respectively. Overall, XFOR moved 140.08% over the past month.
X4 Pharmaceuticals Inc’s market cap currently stands at around $137.41 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 1.06M for the company’s revenue for the quarter, with a low and high estimate of 700k and 1.6M respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that XFOR is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend XFOR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
XFOR’s current price about 44.74% and 58.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.16, while 7-day volatility ratio is 20.75% and 20.53% in the 30-day chart. Further, X4 Pharmaceuticals Inc (XFOR) has a beta value of 0.31, and an average true range (ATR) of 0.11. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $5. Looking at the price targets, the low is -270.37% off current price level while to achieve the yearly target high, price needs to move -517.28%. Nonetheless, investors will most likely welcome a -270.37% jump to $3 which is the analysts’ median price.
If we refocus on X4 Pharmaceuticals Inc (NASDAQ:XFOR), historical trading data shows that trading volumes averaged 3.57 over the past 10 days and 3.18 million over the past 3 months. The company’s latest data on shares outstanding shows there are 168.51 million shares.
The 30.90% of X4 Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 35.58% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.42 million on 2024-10-31, giving us a short ratio of 8.64. The data shows that as of 2024-10-31 short interest in X4 Pharmaceuticals Inc (XFOR) stood at 684.0 of shares outstanding, with shares short falling to 13.56 million registered in 2024-09-30. Current price change has pushed the stock -3.91% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the XFOR stock continues to rise going into the next quarter.
